Skip to content

ENANTA PHARMACEUTICALS, INC: filings

Every ENANTA PHARMACEUTICALS, INC annual and quarterly report in the SEC record with the published financial measures it tagged, 54 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-12fiscal Q3 2026401190001193125-26-345719
10-Q2026-05-13fiscal Q2 2026401150001193125-26-220572
10-Q2026-02-11fiscal Q1 202640830001193125-26-046502
10-K2025-11-19fiscal FY 2025451150001193125-25-288121
10-Q2025-08-13fiscal Q3 2025431240001193125-25-179795
10-Q2025-05-14fiscal Q2 2025431200000950170-25-071340
10-Q2025-02-12fiscal Q1 202443880000950170-25-018810
10-K2024-11-27fiscal FY 2024451160000950170-24-131260
10-Q2024-08-07fiscal Q3 2024431240000950170-24-092714
10-Q2024-05-08fiscal Q2 2024411160000950170-24-055581
10-Q2024-02-08fiscal Q1 202440830000950170-24-012796
10-K2023-11-22fiscal FY 2023441130000950170-23-065884
10-Q2023-08-08fiscal Q3 2023391170000950170-23-039754
10-Q2023-05-09fiscal Q2 2023381090000950170-23-019842
10-Q2023-02-08fiscal Q1 202338790000950170-23-002134
10-K2022-11-23fiscal FY 2022431090000950170-22-025667
10-Q2022-08-08fiscal Q3 2022391160000950170-22-015515
10-Q2022-05-09fiscal Q2 2022391120000950170-22-008483
10-Q2022-02-10fiscal Q1 202239800000950170-22-001018
10-K2021-11-24fiscal FY 2021441120000950170-21-004895
10-Q2021-08-09fiscal Q3 2021391160001564590-21-042612
10-Q2021-05-10fiscal Q2 2021391120001564590-21-026025
10-Q2021-02-09fiscal Q1 202139800001564590-21-004983
10-K2020-11-25fiscal FY 2020441570001564590-20-055233
10-Q2020-08-10fiscal Q3 2020421210001564590-20-038908
10-Q2020-05-11fiscal Q2 2020401120001564590-20-024177
10-Q2020-02-10fiscal Q1 202040810001564590-20-004041
10-K2019-11-27fiscal FY 2019401510001564590-19-044729
10-Q2019-08-09fiscal Q3 2019371100001564590-19-031249
10-Q2019-05-10fiscal Q2 2019371060001564590-19-018517
10-Q2019-02-08fiscal Q1 201937740001564590-19-002428
10-K2018-11-29fiscal FY 2018401520001564590-18-030275
10-Q2018-08-09fiscal Q3 201836980001564590-18-021062
10-Q2018-05-10fiscal Q2 201832900001564590-18-012940
10-Q2018-02-09fiscal Q1 201833680001564590-18-001764
10-K2017-12-11fiscal FY 2017371420001564590-17-024794
10-Q2017-08-09fiscal Q3 201733960001564590-17-016945
10-Q2017-05-10fiscal Q2 201733960001564590-17-010224
10-Q2017-02-09fiscal Q1 201733680001564590-17-001298
10-K2016-12-09fiscal FY 2016381450001193125-16-789660
10-Q2016-08-09fiscal Q3 2016341000001193125-16-676744
10-Q2016-05-10fiscal Q2 2016341000001193125-16-585576
10-Q2016-02-09fiscal Q1 201634700001193125-16-455395
10-K2015-12-11fiscal FY 2015391450001193125-15-401602
10-Q2015-08-10fiscal Q3 201534990001193125-15-284854
10-Q2015-05-08fiscal Q2 201534990001193125-15-179595
10-Q2015-02-06fiscal Q1 201535710001193125-15-037392
10-K2014-12-11fiscal FY 2014411420001193125-14-440235
10-Q2014-08-12fiscal Q3 2014361030001193125-14-305189
10-Q2014-05-12fiscal Q2 2014361020001193125-14-195008
10-Q2014-02-13fiscal Q1 201436740001193125-14-051254
10-K2013-12-18fiscal FY 2013421440001193125-13-477878
10-Q2013-08-12fiscal Q3 2013371000001193125-13-331068
10-Q2013-05-15fiscal Q2 2013371010001193125-13-220330

Inspect the source

Entity
ENANTA PHARMACEUTICALS, INC / CIK 0001177648
Captured
2026-09-20T07:44:57.103Z
SEC response SHA-256
80fddde6209a85211c99bf9c410a8d05c029ccda8597cc49f72b1775c18d6d7b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001177648.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))